JESSICA CRAGER: Open Payments
NPI 1679103642 · PITTSBURG, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$614 in 19 payments from 9 companies in 2025. Trend: 2023 $371 · 2024 $253 · 2025 $614
Food & beverage: $614
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $228 |
| Lilly USA, LLC | 3 | $147 |
| ABBVIE INC. | 4 | $68 |
| Amgen Inc. | 3 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $21 |
| PFIZER INC. | 1 | $20 |
| Novo Nordisk Inc | 1 | $20 |
Products named: MOUNJARO, FARXIGA, BREZTRI, QULIPTA, JARDIANCE, OTEZLA, Auvelity, JOURNAVX.
Industry payments across KS — which companies pay providers there.
